| ID | 64069 |
| Title Alternative | HER2陽性乳癌におけるTrastuzumab・T-DM1耐性化獲得後の治療標的としてのYES1の役割
|
| FullText URL | |
| Author |
FUJIHARA, Miwa
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
|
| Note | 岡山大学審査学位論文
This is an Accepted Manuscript of the article: Fujihara M, Shien T, Shien K, Suzawa K, Takeda T, Zhu Y, Mamori T, Otani Y, Yoshioka R, Uno M, Suzuki Y, Abe Y, Hatono M, Tsukioki T, Takahashi Y, Kochi M, Iwamoto T, Taira N, Doihara H, Toyooka S. YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development. Int J Mol Sci. 2021 Nov 26;22(23):12809.
|
| Published Date | 2022-09-22
|
| Content Type |
Thesis or Dissertation
|
| Grant Number | 甲第6703号
|
| Granted Date | 2022-09-22
|
| Thesis Type |
Doctor of Philosophy in Medical Science
|
| Grantor | 岡山大学
|
| Related Url | isVersionOf https://doi.org/10.3390/ijms222312809
|
| language |
English
|
| File Version | ETD
|
| Grant ID | 15301甲第6703号
|
| PubMed ID | |
| Copyright Holders | © 2021 by the authors.
|
| DOI | |
| License | https://creativecommons.org/licenses/by/4.0/
|
